The clinical outcomes of dapagliflozin in patients with acute heart failure: A randomized controlled trial (DAPA-RESPONSE-AHF)
- 1 November 2023
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 961, 176179
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Biomarkers for Heart Failure: An Update for Practitioners of Internal MedicineThe American Journal of Medicine, 2016
- Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart FailureJACC, 2016
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine, 2015
- Renal effects of dapagliflozin in patients with type 2 diabetesTherapeutic Advances in Endocrinology and Metabolism, 2014
- Diuretic response in acute heart failure: clinical characteristics and prognostic significanceEuropean Heart Journal, 2014
- Physiology of natriuretic peptides: The volume overload hypothesis revisitedWorld Journal of Cardiology, 2014
- Diuretic Strategies in Patients with Acute Decompensated Heart FailureNew England Journal of Medicine, 2011
- Loop Diuretic Therapy in Heart Failure: The Need for Solid Evidence on a Fluid IssueClinical Cardiology, 2010
- EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of populationEuropean Heart Journal, 2006
- Measuring the Dyspnea of Decompensated Heart Failure With a Visual Analog Scale: How Much Improvement Is Meaningful?Congestive Heart Failure, 2004